期刊
NATURE REVIEWS RHEUMATOLOGY
卷 8, 期 12, 页码 710-718出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nrrheum.2012.133
关键词
-
类别
Systemic lupus erythematosus (SLE) is an autoantibody-mediated systemic autoimmune disease, predominantly affecting young females. Pregnancy is increasingly common in the setting of SLE, as survival and quality of life of patients improve. Although live births can be achieved in the most cases, pregnancy in patients with SLE remains a high-risk condition. Maternal and fetal mortality and morbidity are considerably increased, compared with the general population. Aberrations in pregnancy-related maternal immune adaptations are likely contributors. Active maternal disease, renal involvement, specific autoantibody subsets and advanced organ damage are predictors of poor outcome. Therapeutic options are limited during pregnancy as maternal benefit has to be weighed against fetal risk. Prevention of preterm birth and refractory pregnancy loss, as well as management of established neonatal heart block remain unmet needs. Further research should address these important issues that affect young patients with SLE and their babies. Lateef, A. & Petri, M. Nat. Rev. Rheumatol. 8, 710-718 (2012); published online 21 August 2012; doi:10.1038/nrrheum.2012.133
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据